Reporting parties
Subject security
Symbol
FBRX
Shares outstanding
12,693,554 shares
Ownership signal
SEC evidence
Form type
SCHEDULE 13G/A
Filing time
04 Aug 2025, 18:21:26 UTC
Event date
30 Jun 2025
Previous filing
14 Feb 2025
SEC filing
View on sec.gov

Key filing fact

TYBOURNE CAPITAL MANAGEMENT (HK) LTD disclosed 10% ownership in Forte Biosciences, Inc. Common Stock (FBRX) on 30 Jun 2025.

Key facts

  • TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock (FBRX).
  • Disclosed ownership: 10%.
  • Date of event: 30 Jun 2025.

Change

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 04 Aug 2025, 18:21.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (5)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% 1,268,086 0 1,268,086 /s/ Charlotte Fung Charlotte Fung, Chief Financial Officer
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Director
Tybourne Capital Management Ltd 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Tybourne Kesari Ltd 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Krishnan Viswanathan 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Individually
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .